<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35042540</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-994X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Genome medicine</Title><ISOAbbreviation>Genome Med</ISOAbbreviation></Journal><ArticleTitle>Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1.</ArticleTitle><Pagination><StartPage>7</StartPage><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13073-021-01006-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a complex, late-onset, neurodegenerative disease with a genetic contribution to disease liability. Genome-wide association studies (GWAS) have identified ten risk loci to date, including the TNIP1/GPX3 locus on chromosome five. Given association analysis data alone cannot determine the most plausible risk gene for this locus, we undertook a comprehensive suite of in silico, in vivo and in vitro studies to address this.</AbstractText><AbstractText Label="METHODS">The Functional Mapping and Annotation (FUMA) pipeline and five tools (conditional and joint analysis (GCTA-COJO), Stratified Linkage Disequilibrium Score Regression (S-LDSC), Polygenic Priority Scoring (PoPS), Summary-based Mendelian Randomisation (SMR-HEIDI) and transcriptome-wide association study (TWAS) analyses) were used to perform bioinformatic integration of GWAS data (N<sub>cases</sub> = 20,806, N<sub>controls</sub> = 59,804) with 'omics reference datasets including the blood (eQTLgen consortium N = 31,684) and brain (N = 2581). This was followed up by specific expression studies in ALS case-control cohorts (microarray N<sub>total</sub> = 942, protein N<sub>total</sub> = 300) and gene knockdown (KD) studies of human neuronal iPSC cells and zebrafish-morpholinos (MO).</AbstractText><AbstractText Label="RESULTS">SMR analyses implicated both TNIP1 and GPX3 (p &lt; 1.15 &#xd7; 10<sup>-6</sup>), but there was no simple SNP/expression relationship. Integrating multiple datasets using PoPS supported GPX3 but not TNIP1. In vivo expression analyses from blood in ALS cases identified that lower GPX3 expression correlated with a more progressed disease (ALS functional rating score, p = 5.5 &#xd7; 10<sup>-3</sup>, adjusted R<sup>2</sup> = 0.042, B<sub>effect</sub> = 27.4 &#xb1; 13.3&#x2009;ng/ml/ALSFRS unit) with microarray and protein data suggesting lower expression with risk allele (recessive model p = 0.06, p = 0.02 respectively). Validation in vivo indicated gpx3 KD caused significant motor deficits in zebrafish-MO (mean difference vs. control &#xb1; 95% CI, vs. control, swim distance = 112 &#xb1; 28&#x2009;mm, time = 1.29 &#xb1; 0.59 s, speed = 32.0 &#xb1; 2.53&#x2009;mm/s, respectively, p for all &lt;&#x2009;0.0001), which were rescued with gpx3 expression, with no phenotype identified with tnip1 KD or gpx3 overexpression.</AbstractText><AbstractText Label="CONCLUSIONS">These results support GPX3 as a lead ALS risk gene in this locus, with more data needed to confirm/reject a role for TNIP1. This has implications for understanding disease mechanisms (GPX3 acts in the same pathway as SOD1, a well-established ALS-associated gene) and identifying new therapeutic approaches. Few previous examples of in-depth investigations of risk loci in ALS exist and a similar approach could be applied to investigate future expected GWAS findings.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Restuadi</LastName><ForeName>Restuadi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>School of Biomedical Sciences, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, QLD, Brisbane, 4029, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, QLD, Brisbane, 4019, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabashi</LastName><ForeName>Edor</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Imagine Institute, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) Unit&#xe9; 1163, Paris Descartes Universit&#xe9;, 75015, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Universit&#xe9; Pierre et Marie Curie (UPMC), Universit&#xe9; de Paris 06, INSERM Unit&#xe9; 1127, Centre National de la Recherche Scientifique (CNRS) Unit&#xe9; Mixte de Recherche 7225, Institut du Cerveau et de la Moelle &#xc9;pini&#xe8;re (ICM), 75013, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, QLD, Brisbane, 4019, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Fei-Fei</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nabais</LastName><ForeName>Marta F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Exeter Medical School, RILD Building, RD&amp;E Hospital Wonford, Barrack Road, Exeter, EX2 5DW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Mike J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioinformatics, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henders</LastName><ForeName>Anjali K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Leanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bye</LastName><ForeName>Chris R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziser</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Calvary Health Care Bethlehem, Parkdale, VIC, 3195, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCombe</LastName><ForeName>Pamela A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, QLD, Brisbane, 4029, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, QLD, Brisbane, 4019, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Merrilee</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, Perth, WA, 6150, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Notre Dame University, Fremantle, WA, 6160, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Flinders Medical Centre, Bedford Park, SA, 5042, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Brain &amp; Mind Centre, University of Sydney, Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rheenen</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ophoff</LastName><ForeName>Roel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioinformatics, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gusev</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaitlen</LastName><ForeName>Noah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioinformatics, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California Los Angeles, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McRae</LastName><ForeName>Allan F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, QLD, Brisbane, 4029, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, QLD, Brisbane, 4019, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wray</LastName><ForeName>Naomi R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacomotto</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, QLD, Brisbane, 4072, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Centre for Mental Health Research, West Moreton Hospital and Health Service, Wacol, QLD, 4076, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garton</LastName><ForeName>Fleur C</ForeName><Initials>FC</Initials><Identifier Source="ORCID">0000-0002-1490-5930</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, QLD, Brisbane, 4072, Australia. f.garton@uq.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH115676</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HG002536</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genome Med</MedlineTA><NlmUniqueID>101475844</NlmUniqueID><ISSNLinking>1756-994X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Computational biology</Keyword><Keyword MajorTopicYN="N">Disease progression</Keyword><Keyword MajorTopicYN="N">Genes</Keyword><Keyword MajorTopicYN="N">Genome-wide association study</Keyword><Keyword MajorTopicYN="N">MND</Keyword><Keyword MajorTopicYN="N">Motor neurone disease</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Quantitative trait loci</Keyword><Keyword MajorTopicYN="N">Regulator</Keyword><Keyword MajorTopicYN="N">Zebrafish</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35042540</ArticleId><ArticleId IdType="pmc">PMC8767698</ArticleId><ArticleId IdType="doi">10.1186/s13073-021-01006-6</ArticleId><ArticleId IdType="pii">10.1186/s13073-021-01006-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg BB, Garton FC, van Rheenen W, Fang F, Henderson RD, Mortensen PB, Agerbo E, Wray NR. ALS in Danish registries. Neurol Genet. 2020;6(2):e398. doi: 10.1212/NXG.0000000000000398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000398</ArticleId><ArticleId IdType="pmc">PMC7073454</ArticleId><ArticleId IdType="pubmed">32211514</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, Liu Z, Mangelsdorf M, al-Chalabi A, Anderson L, Butler TJ, Chen L, Chen XD, Cremin K, Deng HW, Devine M, Edson J, Fifita JA, Furlong S, Han YY, Harris J, Henders AK, Jeffree RL, Jin ZB, Li Z, Li T, Li M, Lin Y, Liu X, Marshall M, McCann EP, Mowry BJ, Ngo ST, Pamphlett R, Ran S, Reutens DC, Rowe DB, Sachdev P, Shah S, Song S, Tan LJ, Tang L, van den Berg LH, van Rheenen W, Veldink JH, Wallace RH, Wheeler L, Williams KL, Wu J, Wu X, Yang J, Yue W, Zhang ZH, Zhang D, Noakes PG, Blair IP, Henderson RD, McCombe PA, Visscher PM, Xu H, Bartlett PF, Brown MA, Wray NR, Fan D. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun. 2017;8(1):611. doi: 10.1038/s41467-017-00471-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291&#x2013;295. doi: 10.1038/ng.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D, Nalls MA, Hallgr&#xed;msd&#xf3;ttir IB, Hunkapiller J, van der Brug M, Cai F, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson&#x2019;s disease risk loci. Nat Genet. 2017;49(10):1511&#x2013;1516. doi: 10.1038/ng.3955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3955</ArticleId><ArticleId IdType="pmc">PMC5812477</ArticleId><ArticleId IdType="pubmed">28892059</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O&#x2019;Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8(1):14774. doi: 10.1038/ncomms14774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14774</ArticleId><ArticleId IdType="pmc">PMC5364411</ArticleId><ArticleId IdType="pubmed">28322246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;83.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, Hayashi N, Yokoi D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Kanai K, Hattori N, Morita M, Taniguchi A, Kano O, Oda M, Shibuya K, Kuwabara S, Suzuki N, Aoki M, Ohta Y, Yamashita T, Abe K, Hashimoto R, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Okada Y, Ishihara T, Onodera O, Nakashima K, Kaji R, Kamatani Y, Ikegawa S, Momozawa Y, Kubo M, Ishida N, Minegishi N, Nagasaki M, Sobue G. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun Biol. 2020;3(1):526. doi: 10.1038/s42003-020-01251-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="pubmed">32968195</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A, Lin T, Al Khleifat A, Jones AR, Opie-Martin S, Coleman JRI, et al. Genome-wide meta-analysis finds the ACSL5-ZDHHC6 locus is associated with ALS and links weight loss to the disease genetics. Cell Rep. 2020;33(4):108323. doi: 10.1016/j.celrep.2020.108323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108323</ArticleId><ArticleId IdType="pmc">PMC7610013</ArticleId><ArticleId IdType="pubmed">33113361</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545(7655):505&#x2013;509. doi: 10.1038/nature22366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22366</ArticleId><ArticleId IdType="pmc">PMC5531611</ArticleId><ArticleId IdType="pubmed">28514442</ArticleId></ArticleIdList></Reference><Reference><Citation>Luck K, Kim D-K, Lambourne L, Spirohn K, Begg BE, Bian W, Brignall R, Cafarelli T, Campos-Laborie FJ, Charloteaux B, Choi D, Cot&#xe9; AG, Daley M, Deimling S, Desbuleux A, Dricot A, Gebbia M, Hardy MF, Kishore N, Knapp JJ, Kov&#xe1;cs IA, Lemmens I, Mee MW, Mellor JC, Pollis C, Pons C, Richardson AD, Schlabach S, Teeking B, Yadav A, Babor M, Balcha D, Basha O, Bowman-Colin C, Chin SF, Choi SG, Colabella C, Coppin G, D&#x2019;Amata C, de Ridder D, de Rouck S, Duran-Frigola M, Ennajdaoui H, Goebels F, Goehring L, Gopal A, Haddad G, Hatchi E, Helmy M, Jacob Y, Kassa Y, Landini S, Li R, van Lieshout N, MacWilliams A, Markey D, Paulson JN, Rangarajan S, Rasla J, Rayhan A, Rolland T, San-Miguel A, Shen Y, Sheykhkarimli D, Sheynkman GM, Simonovsky E, Ta&#x15f;an M, Tejeda A, Tropepe V, Twizere JC, Wang Y, Weatheritt RJ, Weile J, Xia Y, Yang X, Yeger-Lotem E, Zhong Q, Aloy P, Bader GD, de Las Rivas J, Gaudet S, Hao T, Rak J, Tavernier J, Hill DE, Vidal M, Roth FP, Calderwood MA. A reference map of the human binary protein interactome. Nature. 2020;580(7803):402&#x2013;408. doi: 10.1038/s41586-020-2188-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2188-x</ArticleId><ArticleId IdType="pmc">PMC7169983</ArticleId><ArticleId IdType="pubmed">32296183</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Shimazawa M, Takata M, Kaneko H, Tsuruma K, Ikeda T, Warita H, Aoki M, Yamada M, Takahashi H, Hozumi I, Minatsu H, Inuzuka T, Hara H. ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis. J Neurol. 2013;260(7):1782&#x2013;1797. doi: 10.1007/s00415-013-6877-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-6877-3</ArticleId><ArticleId IdType="pubmed">23436019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177&#x2013;183. doi: 10.1038/nature16549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16549</ArticleId><ArticleId IdType="pmc">PMC4752392</ArticleId><ArticleId IdType="pubmed">26814963</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards SL, Beesley J, French JD, Dunning AM. Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet. 2013;93(5):779&#x2013;797. doi: 10.1016/j.ajhg.2013.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.10.012</ArticleId><ArticleId IdType="pmc">PMC3824120</ArticleId><ArticleId IdType="pubmed">24210251</ArticleId></ArticleIdList></Reference><Reference><Citation>K-l H, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer&#x2019;s disease. Nat Neurosci. 2017;20(8):1052&#x2013;1061. doi: 10.1038/nn.4587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4587</ArticleId><ArticleId IdType="pmc">PMC5759334</ArticleId><ArticleId IdType="pubmed">28628103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, Montgomery GW, Goddard ME, Wray NR, Visscher PM, Yang J. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481&#x2013;487. doi: 10.1038/ng.3538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3538</ArticleId><ArticleId IdType="pubmed">27019110</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826. doi: 10.1038/s41467-017-01261-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01261-5</ArticleId><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Umi&#x107;evi&#x107; Mirkov M, de Leeuw CA, van den Heuvel MP, Posthuma D. Genetic mapping of cell type specificity for complex traits. Nat Commun. 2019;10(1):3222. doi: 10.1038/s41467-019-11181-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11181-1</ArticleId><ArticleId IdType="pmc">PMC6642112</ArticleId><ArticleId IdType="pubmed">31324783</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh P-R, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47(11):1228&#x2013;1235. doi: 10.1038/ng.3404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3404</ArticleId><ArticleId IdType="pmc">PMC4626285</ArticleId><ArticleId IdType="pubmed">26414678</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK, Reshef YA, Anttila V, Slowikowski K, Gusev A, Byrnes A, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat Genet. 2018;50(4):621&#x2013;629. doi: 10.1038/s41588-018-0081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0081-4</ArticleId><ArticleId IdType="pmc">PMC5896795</ArticleId><ArticleId IdType="pubmed">29632380</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks EM, Ulirsch JC, Cheng NY, Trippe BL, Fine RS, Miao J, et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. medRxiv. 2020; 2020.09.08.20190561.</Citation></Reference><Reference><Citation>Restuadi R, Garton FC, Benyamin B, Lin T, Williams KL, Vinkhuyzen A, et al. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia. Eur J Hum Genet. 2021. 10.1038/s41431-021-00885-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">33907316</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68&#x2013;74. doi: 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11(4):e1004219-e. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Subramanian A, Pinchback R, Thorvaldsd&#xf3;ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics (Oxford, England) 2011;27(12):1739&#x2013;1740. doi: 10.1093/bioinformatics/btr260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science (New York, NY) 2018;362(6420):eaat8127. doi: 10.1126/science.aat8127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat8127</ArticleId><ArticleId IdType="pmc">PMC6443102</ArticleId><ArticleId IdType="pubmed">30545856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziats MN, Rennert OM. Identification of differentially expressed microRNAs across the developing human brain. Mol Psychiatr. 2014;19(7):848&#x2013;852. doi: 10.1038/mp.2013.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.93</ArticleId><ArticleId IdType="pmc">PMC3840150</ArticleId><ArticleId IdType="pubmed">23917947</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57&#x2013;74. doi: 10.1038/nature11247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11247</ArticleId><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Roadmap Epigenomics C, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317&#x2013;330. doi: 10.1038/nature14248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14248</ArticleId><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT, Laboratory DA, Coordinating Center &#x2014;Analysis Working G. Statistical Methods groups&#x2014;Analysis Working G. Enhancing Gg. Fund NIHC et al. Genetic effects on gene expression across human tissues. Nature. 2017;550(7675):204&#x2013;213. doi: 10.1038/nature24277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24277</ArticleId><ArticleId IdType="pmc">PMC5776756</ArticleId><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Wijst MGP, Brugge H, de Vries DH, Deelen P, Swertz MA, LifeLines Cohort S, et al. Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs. Nat Genet. 2018;50(4):493&#x2013;497. doi: 10.1038/s41588-018-0089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0089-9</ArticleId><ArticleId IdType="pmc">PMC5905669</ArticleId><ArticleId IdType="pubmed">29610479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ferreira T, Morris AP, Medland SE. Genetic Investigation of ATC, Replication DIG, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44(4):369&#x2013;3S3. doi: 10.1038/ng.2213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2213</ArticleId><ArticleId IdType="pmc">PMC3593158</ArticleId><ArticleId IdType="pubmed">22426310</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xf5;sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis. bioRxiv. 2018:447367.</Citation></Reference><Reference><Citation>Qi T, Wu Y, Zeng J, Zhang F, Xue A, Jiang L, et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat Commun. 2018;9(1):2282. doi: 10.1038/s41467-018-04558-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04558-1</ArticleId><ArticleId IdType="pmc">PMC5995828</ArticleId><ArticleId IdType="pubmed">29891976</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, Ruderfer DM, Oh EC, Topol A, Shah HR, Klei LL, Kramer R, Pinto D, G&#xfc;m&#xfc;&#x15f; ZH, Cicek AE, Dang KK, Browne A, Lu C, Xie L, Readhead B, Stahl EA, Xiao J, Parvizi M, Hamamsy T, Fullard JF, Wang YC, Mahajan MC, Derry JMJ, Dudley JT, Hemby SE, Logsdon BA, Talbot K, Raj T, Bennett DA, de Jager PL, Zhu J, Zhang B, Sullivan PF, Chess A, Purcell SM, Shinobu LA, Mangravite LM, Toyoshiba H, Gur RE, Hahn CG, Lewis DA, Haroutunian V, Peters MA, Lipska BK, Buxbaum JD, Schadt EE, Hirai K, Roeder K, Brennand KJ, Katsanis N, Domenici E, Devlin B, Sklar P. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19(11):1442&#x2013;1453. doi: 10.1038/nn.4399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4399</ArticleId><ArticleId IdType="pmc">PMC5083142</ArticleId><ArticleId IdType="pubmed">27668389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng B, White CC, Klein H-U, Sieberts SK, McCabe C, Patrick E, Xu J, Yu L, Gaiteri C, Bennett DA, Mostafavi S, de Jager PL. An xQTL map integrates the genetic architecture of the human brain&#x2019;s transcriptome and epigenome. Nat Neurosci. 2017;20(10):1418&#x2013;1426. doi: 10.1038/nn.4632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4632</ArticleId><ArticleId IdType="pmc">PMC5785926</ArticleId><ArticleId IdType="pubmed">28869584</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabzuni D, Ryten M, Walker R, Smith C, Imran S, Ramasamy A, Weale ME, Hardy J. Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J Neurochem. 2011;119(2):275&#x2013;282. doi: 10.1111/j.1471-4159.2011.07432.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07432.x</ArticleId><ArticleId IdType="pmc">PMC3664422</ArticleId><ArticleId IdType="pubmed">21848658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, et al. Comprehensive functional genomic resource and integrative model for the human brain. Science (New York, NY) 2018;362(6420):eaat8464. doi: 10.1126/science.aat8464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat8464</ArticleId><ArticleId IdType="pmc">PMC6413328</ArticleId><ArticleId IdType="pubmed">30545857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BWJH, Jansen R, de Geus EJC, Boomsma DI, Wright FA, Sullivan PF, Nikkola E, Alvarez M, Civelek M, Lusis AJ, Lehtim&#xe4;ki T, Raitoharju E, K&#xe4;h&#xf6;nen M, Sepp&#xe4;l&#xe4; I, Raitakari OT, Kuusisto J, Laakso M, Price AL, Pajukanta P, Pasaniuc B. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245&#x2013;252. doi: 10.1038/ng.3506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3506</ArticleId><ArticleId IdType="pmc">PMC4767558</ArticleId><ArticleId IdType="pubmed">26854917</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Gordon MG, Lu A, Tandon A, Halperin E, Gusev A, et al. Multi-context genetic modeling of transcriptional regulation resolves novel disease loci. bioRxiv. 2021; 2021.09.23.461579.</Citation></Reference><Reference><Citation>Lu A, Thompson M, Grace Gordon M, Dahl A, Ye CJ, Zaitlen N, et al. Fast and powerful statistical method for context-specific QTL mapping in multi-context genomic studies. bioRxiv. 2021; 2021.06.17.448889.</Citation></Reference><Reference><Citation>Peterson CB, Bogomolov M, Benjamini Y, Sabatti C. TreeQTL: hierarchical error control for eQTL findings. Bioinformatics (Oxford, England) 2016;32(16):2556&#x2013;2558. doi: 10.1093/bioinformatics/btw198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw198</ArticleId><ArticleId IdType="pmc">PMC4978936</ArticleId><ArticleId IdType="pubmed">27153635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui L-Y, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabais MF, Lin T, Benyamin B, Williams KL, Garton FC, AAE V, et al. Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis. npj Genom Med. 2020;5(1):10. doi: 10.1038/s41525-020-0118-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-020-0118-3</ArticleId><ArticleId IdType="pmc">PMC7046630</ArticleId><ArticleId IdType="pubmed">32140259</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Diekstra FP, Harschnitz O, Westeneng H-J, van Eijk KR, Saris CGJ, Groen EJN, van Es MA, Blauw HM, van Vught PWJ, Veldink JH, van den Berg LH. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: a biomarker study. PloS One. 2018;13(6):e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 2007;3(9):1724&#x2013;1735. doi: 10.1371/journal.pgen.0030161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030161</ArticleId><ArticleId IdType="pmc">PMC1994707</ArticleId><ArticleId IdType="pubmed">17907809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22-e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389466</ArticleId><ArticleId IdType="pubmed">27924034</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 1998;282(5391):1145. doi: 10.1126/science.282.5391.1145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.282.5391.1145</ArticleId><ArticleId IdType="pubmed">9804556</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z-W, Chen H, Liu H, Lu J, Qian K, Huang C-L, et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun. 2015;6(1):6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod VM, Lau CL, Chiam MDF, Rupasinghe TW, Roessner U, Djouma E, Boon WC, Turner BJ. Androgen receptor antagonism accelerates disease onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Br J Pharmacol. 2019;176(13):2111&#x2013;2130. doi: 10.1111/bph.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14657</ArticleId><ArticleId IdType="pmc">PMC6555856</ArticleId><ArticleId IdType="pubmed">30849180</ArticleId></ArticleIdList></Reference><Reference><Citation>Blakely BD, Bye CR, Fernando CV, Horne MK, Macheda ML, Stacker SA, Arenas E, Parish CL. Wnt5a regulates midbrain dopaminergic axon growth and guidance. PloS One. 2011;6(3):e18373. doi: 10.1371/journal.pone.0018373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018373</ArticleId><ArticleId IdType="pmc">PMC3069098</ArticleId><ArticleId IdType="pubmed">21483795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo W, Mitra J, Hegde PM, Vandoorne T, Eckelmann BJ, Mitra S, Tomkinson AE, van den Bosch L, Hegde ML. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in amyotrophic lateral sclerosis. Nat Commun. 2018;9(1):3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzardini M, Mangolini A, Lupi M, Ubezio P, Bendotti C, Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J Neurol Sci. 2005;232(1):95&#x2013;103. doi: 10.1016/j.jns.2005.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.004</ArticleId><ArticleId IdType="pubmed">15850589</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossoll W, Jablonka S, Andreassi C, Kr&#xf6;ning A-K, Karle K, Monani UR, et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol. 2003;163(4):801&#x2013;812. doi: 10.1083/jcb.200304128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200304128</ArticleId><ArticleId IdType="pmc">PMC2173668</ArticleId><ArticleId IdType="pubmed">14623865</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012;18(9):1418&#x2013;1422. doi: 10.1038/nm.2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2901</ArticleId><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol. 2013;74(2):180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Montal V, Sirisi S, L&#xf3;pez-Pernas G, Cervera-Carles L, Querol-Vilaseca M, Mu&#xf1;oz L, Belbin O, Alcolea D, Molina-Porcel L, Pegueroles J, Tur&#xf3;n-Sans J, Blesa R, Lle&#xf3; A, Fortea J, Rojas-Garc&#xed;a R, Clarim&#xf3;n J. Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e829. doi: 10.1212/NXI.0000000000000829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, Kouloura E, Gray E, Thompson AG, Talbot K, Higginbottom A, Myszczynska M, Allen CF, Stopford MJ, Hemingway J, Bauer CS, Webster CP, de Vos KJ, Turner MR, Keun HC, Hautbergue GM, Ferraiuolo L, Shaw PJ. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain J Neurol. 2019;142(3):586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey D, Fauman EB, Ziemek D, Sun BB, Harshfield EL, Wood AM, et al. ProGeM: a framework for the prioritization of candidate causal genes at molecular quantitative trait loci. Nucleic Acids Res. 2019;47(1):e3-e. doi: 10.1093/nar/gky837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky837</ArticleId><ArticleId IdType="pmc">PMC6326795</ArticleId><ArticleId IdType="pubmed">30239796</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J, Wolfs MGM, Deelen P, Westra H-J, Fehrmann RSN, te Meerman GJ, Buurman WA, Rensen SSM, Groen HJM, Weersma RK, van den Berg LH, Veldink J, Ophoff RA, Snieder H, van Heel D, Jansen RC, Hofker MH, Wijmenga C, Franke L. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLOS Genet. 2012;8(1):e1002431. doi: 10.1371/journal.pgen.1002431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002431</ArticleId><ArticleId IdType="pmc">PMC3261927</ArticleId><ArticleId IdType="pubmed">22275870</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95(25):14863&#x2013;14868. doi: 10.1073/pnas.95.25.14863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.25.14863</ArticleId><ArticleId IdType="pmc">PMC24541</ArticleId><ArticleId IdType="pubmed">9843981</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xf5;sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Yazar S, Brugge H, Oelen R, de Vries DH, van der Wijst MGP, Kasela S, Pervjakova N, Alves I, Fav&#xe9; MJ, Agbessi M, Christiansen MW, Jansen R, Sepp&#xe4;l&#xe4; I, Tong L, Teumer A, Schramm K, Hemani G, Verlouw J, Yaghootkar H, S&#xf6;nmez Flitman R, Brown A, Kukushkina V, Kalnapenkis A, R&#xfc;eger S, Porcu E, Kronberg J, Kettunen J, Lee B, Zhang F, Qi T, Hernandez JA, Arindrarto W, Beutner F, BIOS Consortium. &#x2019;t Hoen PAC, van Meurs J, van Dongen J, van Iterson M, Swertz MA, i2QTL Consortium. Jan Bonder M, Dmitrieva J, Elansary M, Fairfax BP, Georges M, Heijmans BT, Hewitt AW, K&#xe4;h&#xf6;nen M, Kim Y, Knight JC, Kovacs P, Krohn K, Li S, Loeffler M, Marigorta UM, Mei H, Momozawa Y, M&#xfc;ller-Nurasyid M, Nauck M, Nivard MG, Penninx BWJH, Pritchard JK, Raitakari OT, Rotzschke O, Slagboom EP, Stehouwer CDA, Stumvoll M, Sullivan P, &#x2019;t Hoen PAC, Thiery J, T&#xf6;njes A, van Dongen J, van Iterson M, Veldink JH, V&#xf6;lker U, Warmerdam R, Wijmenga C, Swertz M, Andiappan A, Montgomery GW, Ripatti S, Perola M, Kutalik Z, Dermitzakis E, Bergmann S, Frayling T, van Meurs J, Prokisch H, Ahsan H, Pierce BL, Lehtim&#xe4;ki T, Boomsma DI, Psaty BM, Gharib SA, Awadalla P, Milani L, Ouwehand WH, Downes K, Stegle O, Battle A, Visscher PM, Yang J, Scholz M, Powell J, Gibson G, Esko T, Franke L. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300&#x2013;1310. doi: 10.1038/s41588-021-00913-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00913-z</ArticleId><ArticleId IdType="pmc">PMC8432599</ArticleId><ArticleId IdType="pubmed">34475573</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Li X, Chang T-W, Weiss ST, Qiu W. powerEQTL: an R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis. bioRxiv. 2020; 2020.12.15.422954.</Citation><ArticleIdList><ArticleId IdType="pubmed">34009297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Brustein E, Champagne N, Drapeau P. Zebrafish models for the functional genomics of neurogenetic disorders. Biochimica et Biophysica Acta (BBA) &#x2013; Mol Basis Dis. 2011;1812(3):335&#x2013;345. doi: 10.1016/j.bbadis.2010.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2010.09.011</ArticleId><ArticleId IdType="pubmed">20887784</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice JR, Gregory-Evans CY, Shaw CA. Animal models of amyotrophic lateral sclerosis: a comparison of model validity. Neural Regen Res. 2018;13(12):2050&#x2013;2054. doi: 10.4103/1673-5374.241445.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241445</ArticleId><ArticleId IdType="pmc">PMC6199948</ArticleId><ArticleId IdType="pubmed">30323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Serbanovic-Canic J, de Luca A, Warboys C, Ferreira Pedro F, Luong Le A, Hsiao S, et al. Zebrafish model for functional screening of flow-responsive genes. Arterioscler Thromb Vasc Biol 2017;37(1):130-143, 10.1161/ATVBAHA.116.308502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5172514</ArticleId><ArticleId IdType="pubmed">27834691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Jiang J, Yan H, Li Y, Zhao J, Wang X, et al. ABIN-1 negatively regulates &#x3bc;-opioid receptor function. Mol Pharmacol. 2017:mol.117.109009.</Citation><ArticleIdList><ArticleId IdType="pubmed">29237725</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanno S-I, Tomizawa A, Yomogida S, Hara A. Glutathione peroxidase 3 is a protective factor against acetaminophen-induced hepatotoxicity in vivo and in vitro. Int J Mol Med. 2017;40(3):748&#x2013;754. doi: 10.3892/ijmm.2017.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3049</ArticleId><ArticleId IdType="pmc">PMC5547967</ArticleId><ArticleId IdType="pubmed">28677736</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels C, Raes M, Toussaint O, Remacle J. Importance of SE-glutathione peroxidase, catalase, and CU/ZN-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17(3):235&#x2013;248. doi: 10.1016/0891-5849(94)90079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(94)90079-5</ArticleId><ArticleId IdType="pubmed">7982629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirochnitchenko O, Weisbrot-Lefkowitz M, Reuhl K, Chen L, Yang C, Inouye M. Acetaminophen toxicity: opposite effects of two forms of glutathione peroxidase*. J Biol Chem. 1999;274(15):10349&#x2013;10355. doi: 10.1074/jbc.274.15.10349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.15.10349</ArticleId><ArticleId IdType="pubmed">10187823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Kralj JM, Zou P, Weinstein EN, Zhang H, Tsioras K, Wiskow O, Ortega JA, Eggan K, Cohen AE. All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS. Stem Cell Rep. 2018;10(6):1991&#x2013;2004. doi: 10.1016/j.stemcr.2018.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.04.020</ArticleId><ArticleId IdType="pmc">PMC5993648</ArticleId><ArticleId IdType="pubmed">29779896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, Hadano S, Aoki M, Saya H, Sobue G, Okano H. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24(10):1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian R, Gachechiladze MA, Ludwig CH, Laurie MT, Hong JY, Nathaniel D, et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron. 2019;104(2):239&#x2013;55.e12. doi: 10.1016/j.neuron.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.07.014</ArticleId><ArticleId IdType="pmc">PMC6813890</ArticleId><ArticleId IdType="pubmed">31422865</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem. 2004;279(26):26839&#x2013;26845. doi: 10.1074/jbc.M401907200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M401907200</ArticleId><ArticleId IdType="pubmed">15096516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17(10):1418&#x2013;1428. doi: 10.1038/nn.3801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3801</ArticleId><ArticleId IdType="pmc">PMC4208299</ArticleId><ArticleId IdType="pubmed">25174004</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Investig. 1996;97(4):979&#x2013;987. doi: 10.1172/JCI118522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118522</ArticleId><ArticleId IdType="pmc">PMC507144</ArticleId><ArticleId IdType="pubmed">8613552</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter M, Pearson DJ, Suarez-Mendez VJ, Blann AD. Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man. Clin Sci. 1992;83(3):343&#x2013;345. doi: 10.1042/cs0830343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0830343</ArticleId><ArticleId IdType="pubmed">1327653</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Richard C, Mahoney Christopher E, Anderson L, Ottaviano F, Croce K, Leopold Jane A, et al. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation. 2011;123(18):1963&#x2013;1973. doi: 10.1161/CIRCULATIONAHA.110.000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.000034</ArticleId><ArticleId IdType="pmc">PMC3107543</ArticleId><ArticleId IdType="pubmed">21518981</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Gonzalez D, Cortes N, Ampuero E, Hern&#xe1;ndez DE, Fritz E, et al. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front Cellular Neurosci. 2015;9:203. doi: 10.3389/fncel.2015.00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00203</ArticleId><ArticleId IdType="pmc">PMC4460879</ArticleId><ArticleId IdType="pubmed">26106294</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochimica et Biophysica Acta (BBA) &#x2013; Mol Basis Dis. 2006;1762(11):1051&#x2013;1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino JJ, Roncero C, Oset-Gasque MJ, Naddaf A, Gonz&#xe1;lez MP. Antioxidant and protective mechanisms against hypoxia and hypoglycaemia in cortical neurons in vitro. Int J Mol Sci. 2014;15(2):2475&#x2013;2493. doi: 10.3390/ijms15022475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms15022475</ArticleId><ArticleId IdType="pmc">PMC3958863</ArticleId><ArticleId IdType="pubmed">24526229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathologica. 2005;110(2):101&#x2013;112. doi: 10.1007/s00401-005-1019-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-005-1019-3</ArticleId><ArticleId IdType="pubmed">15983830</ArticleId></ArticleIdList></Reference><Reference><Citation>Capper MJ, Wright GSA, Barbieri L, Luchinat E, Mercatelli E, McAlary L, Yerbury JJ, O&#x2019;Neill PM, Antonyuk SV, Banci L, Hasnain SS. The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation. Nat Commun. 2018;9(1):1693. doi: 10.1038/s41467-018-04114-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04114-x</ArticleId><ArticleId IdType="pmc">PMC5923229</ArticleId><ArticleId IdType="pubmed">29703933</ArticleId></ArticleIdList></Reference><Reference><Citation>Amporndanai K, Rogers M, Watanabe S, Yamanaka K, O&#x2019;Neill PM, Hasnain SS. Novel selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis. EBioMedicine. 2020;59:102980. doi: 10.1016/j.ebiom.2020.102980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102980</ArticleId><ArticleId IdType="pmc">PMC7456458</ArticleId><ArticleId IdType="pubmed">32862101</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf&#xf6;ldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O&#x2019;Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Genome Aggregation Database Consortium. Aguilar Salinas CA, Ahmad T, Albert CM, Ardissino D, Atzmon G, Barnard J, Beaugerie L, Benjamin EJ, Boehnke M, Bonnycastle LL, Bottinger EP, Bowden DW, Bown MJ, Chambers JC, Chan JC, Chasman D, Cho J, Chung MK, Cohen B, Correa A, Dabelea D, Daly MJ, Darbar D, Duggirala R, Dupuis J, Ellinor PT, Elosua R, Erdmann J, Esko T, F&#xe4;rkkil&#xe4; M, Florez J, Franke A, Getz G, Glaser B, Glatt SJ, Goldstein D, Gonzalez C, Groop L, Haiman C, Hanis C, Harms M, Hiltunen M, Holi MM, Hultman CM, Kallela M, Kaprio J, Kathiresan S, Kim BJ, Kim YJ, Kirov G, Kooner J, Koskinen S, Krumholz HM, Kugathasan S, Kwak SH, Laakso M, Lehtim&#xe4;ki T, Loos RJF, Lubitz SA, Ma RCW, MacArthur DG, Marrugat J, Mattila KM, McCarroll S, McCarthy MI, McGovern D, McPherson R, Meigs JB, Melander O, Metspalu A, Neale BM, Nilsson PM, O&#x2019;Donovan MC, Ongur D, Orozco L, Owen MJ, Palmer CNA, Palotie A, Park KS, Pato C, Pulver AE, Rahman N, Remes AM, Rioux JD, Ripatti S, Roden DM, Saleheen D, Salomaa V, Samani NJ, Scharf J, Schunkert H, Shoemaker MB, Sklar P, Soininen H, Sokol H, Spector T, Sullivan PF, Suvisaari J, Tai ES, Teo YY, Tiinamaija T, Tsuang M, Turner D, Tusie-Luna T, Vartiainen E, Vawter MP, Ware JS, Watkins H, Weersma RK, Wessman M, Wilson JG, Xavier RJ, Neale BM, Daly MJ, MacArthur DG. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K, Ostrow LW, Schoenfeld D, Macklin EA, Norris DA, Manousakis G, Crisp M, Smith R, Bennett CF, Bishop KM, Cudkowicz ME. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12(5):435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, Liefhebber JM, Garc&#xed;a-Osta A, Miniarikova J, Cuadrado-Tejedor M, Espelosin M, Ursua S, Petry H, van Deventer SJ, Evers MM, Konstantinova P. Targeting RNA-mediated toxicity in C9orf72 ALS and/or FTD by RNAi-based gene therapy. Mol Ther - Nucleic Acids. 2019;16:26&#x2013;37. doi: 10.1016/j.omtn.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6393708</ArticleId><ArticleId IdType="pubmed">30825670</ArticleId></ArticleIdList></Reference><Reference><Citation>Restuadi R, Steyn FJ, Kabashi E, Ngo ST, Cheng F-F, Nabais MF, et al. ALS-GPX3-TNIP1 Github. https://github.com/CNSGenomics/ALS-GPX3-TNIP1 (2021). Accessed December 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>